Skip To Main Content
M. Metawe on Muck Rack

M. Metawe

As seen in: Clinical Oncology
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with M.

Contact M., search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

HDR Prostate Brachytherapy Boost for T3b Cancer: The Stokes Centre for Urology Experience

|
By M. Metawe, S. K. Mehta, S. Uribe, S. Otter
| Clinical Oncology Verified
M. Metawe S. Mehta S. Uribe S. Otter M. Long S. Langley Purpose: High dose rate prostate brachytherapy (HDR-PB) with external beam radiotherapy (EBRT) and androgen deprivation (ADT) allows dose escalation and is an effective treatment for patients with high-risk prostate cancer [1,2]. The purpose of this study was to present the experience of the Stokes Centre for Urology with HDR-PB, looking at dosimetry and biochemical control.
Open in Who Shared View Duplicates (10) Issue with article?
See all 1 articles